Search Results - Yu. V. Medvedev

Refine Results
  1. 1
    Inertial regimes of viscous fluid flow in the low-height cylinder with rotating bases

    Inertial regimes of viscous fluid flow in the low-height cylinder with rotating bases by V. K. Akhmetov, Yu. V. Medvedev, V. Ya. Shkhadov

    Published 2016-11-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Biowaiver as a Bioequivalence Study Option

    Biowaiver as a Bioequivalence Study Option by E. A. Volkova, Yu. V. Medvedev, E. N. Fisher, I. E. Shohin

    Published 2024-02-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    The determination of topiramate in plasma rabbit blood by HPLC with specific derivatization

    The determination of topiramate in plasma rabbit blood by HPLC with specific derivatization by G. V. Ramenskaya, M. A. Sheveleva, I. E. Shokhin, Yu. V. Medvedev, T. A. Yarushok

    Published 2011-09-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Development and validation of the methods for determination of tenophovir in the blood plasma of rabbits

    Development and validation of the methods for determination of tenophovir in the blood plasma of rabbits by Yu. V. Medvedev, G. V. Ramenskaya, I. E. Shokhin, T. A. Yarushok, M. A. Sheveleva

    Published 2011-09-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    DISSOLUTION PROFILE STUDY FOR INNOVATION ANTI-RETROVIRAL DRUG PRODUCT NIKAVIR® AND ITS FIXED COMBINATION WITH LAMIVUDINE (PHOSPHALADINE®)

    DISSOLUTION PROFILE STUDY FOR INNOVATION ANTI-RETROVIRAL DRUG PRODUCT NIKAVIR® AND ITS FIXED COMBINATION WITH LAMIVUDINE (PHOSPHALADINE®) by I. E. Shohin, Yu. V. Medvedev, T. N. Komarov, O. V. Klimova, B. V. Brovchenko

    Published 2019-01-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS Method

    Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS Method by D. S. Bogdanova, T. N. Komarov, I. E. Shohin, E. S. Melnikov, O. A. Miskiv, Yu. V. Medvedev

    Published 2019-05-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    VALIDATION OF UV-SPECTROMETRY ASSAY METHOD FOR DISSOLUTION PROFILE TEST FOR LEVOFLOXACINE TABLETS

    VALIDATION OF UV-SPECTROMETRY ASSAY METHOD FOR DISSOLUTION PROFILE TEST FOR LEVOFLOXACINE TABLETS by A. A. Lvova, I. E. Shohin, L. A. Menshikova, T. N. Komarov, Yu. E. Boldina, Yu. V. Medvedev

    Published 2019-01-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    HPLC-UV Method Development and Validation for Vitamin D<sub>3</sub> (Cholecalciferol) Quantitation in Drugs and Dietary Supplements

    HPLC-UV Method Development and Validation for Vitamin D<sub>3</sub> (Cholecalciferol) Quantitation in Drugs and Dietary Supplements by I. E. Shohin, E. A. Malashenko, Yu. V. Medvedev, M. N. Bogachuk, S. A. Kulakov, M. A. Paleeva

    Published 2021-05-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    VALIDATION OF UV-SPECTROMETRY ASSAY METHOD FOR DISSOLUTION PROFILE TEST FOR MOXIFLOXACINE TABLETS

    VALIDATION OF UV-SPECTROMETRY ASSAY METHOD FOR DISSOLUTION PROFILE TEST FOR MOXIFLOXACINE TABLETS by L. A. Menshikova, A. A. Lvova, I. E. Shohin, Yu. E. Boldina, T. N. Komarov, Yu. V. Medvedev

    Published 2019-01-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Erratum: "HPLC-UV Method Development and Validation for Vitamin D<sub>3</sub> (Cholecalciferol) Quantitationin Drugs and Dietary Supplements"

    Erratum: "HPLC-UV Method Development and Validation for Vitamin D<sub>3</sub> (Cholecalciferol) Quantitationin Drugs and Dietary Supplements" by I. E. Shohin, E. A. Malashenko, Yu. V. Medvedev, M. N. Bogachuk, S. A. Kulakov, M. A. Paleeva

    Published 2021-11-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    DISSOLUTION PROFILE STUDY FOR EXTENDED RELEASE VALPROIC ACID DOSAGE FORM (DEPAKINE® CHRONO)

    DISSOLUTION PROFILE STUDY FOR EXTENDED RELEASE VALPROIC ACID DOSAGE FORM (DEPAKINE® CHRONO) by A. A. Lvova, Yu. E. Boldina, I. E. Shohin, T. N. Komarov, L. A. Menshikova, Yu. V. Medvedev

    Published 2019-01-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-UV Method

    Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-UV Method by T. N. Komarov, I. E. Shohin, O. A. Miskiv, D. S. Bogdanova, A. V. Aleshina, Yu. V. Medvedev, N. S. Bagaeva

    Published 2020-05-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Development and Validation of Atazanavir and Ritonavir Determination in Human Plasma by HPLC-MS Method

    Development and Validation of Atazanavir and Ritonavir Determination in Human Plasma by HPLC-MS Method by T. N. Komarov, I. E. Shohin, O. A. Miskiv, D. S. Bogdanova, A. V. Aleshina, Yu. V. Medvedev, N. S. Bagaeva

    Published 2020-02-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    Comparative Analysis of Dalargin Pharmaceutical Substance Identification Methods

    Comparative Analysis of Dalargin Pharmaceutical Substance Identification Methods by M. G. Shulzhenko, I. A. Vasilenko, B. I. Ugrak, I. E. Shohin, Yu. V. Medvedev, E. A. Malashenko

    Published 2020-08-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Immunogenicity Assessment of Pegfilgrastim in Patients with Breast Cancer

    Immunogenicity Assessment of Pegfilgrastim in Patients with Breast Cancer by Yu. V. Medvedev, M. A. Kolganova, O. A. Sas, T. N. Komarov, E. N. Fisher, I. E. Shohin, Yu. I. Ammour

    Published 2020-05-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Approaches to conducting a physiologically relevant test (PRT) in the study of medicines containing substance IIc of the BCS subclass using sorafenib as an example

    Approaches to conducting a physiologically relevant test (PRT) in the study of medicines containing substance IIc of the BCS subclass using sorafenib as an example by A. V. Suvorova, Yu. V. Medvedev, P. A. Losenkova, O. S. Kramarenko, E. A. Malashenko, A. M. Poluyanov, I. E. Shohin

    Published 2024-09-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    Development and Validation of Salbutamol, Bromhexine, Ambroxol and Guauaifenesin Determination in Human Plasma by HPLC-MS/MS Method

    Development and Validation of Salbutamol, Bromhexine, Ambroxol and Guauaifenesin Determination in Human Plasma by HPLC-MS/MS Method by T. N. Komarov, D. S. Bogdanova, O. A. Miskiv, A. V. Aleshina, I. E. Shohin, Yu. V. Medvedev, N. S. Bagaeva, I. M. Korenskaya

    Published 2019-11-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    PRT to predict pharmacokinetic profiles as part of a bioequivalence study of the drug deferasirox

    PRT to predict pharmacokinetic profiles as part of a bioequivalence study of the drug deferasirox by A. V. Suvorova, P. A. Losenkova, Yu. V. Medvedev, E. A. Malashenko, I. E. Makarenko, A. M. Poluyanov, I. E. Shohin

    Published 2024-09-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    Chemical and Toxicological Analysis of Antiretroviral Drugs

    Chemical and Toxicological Analysis of Antiretroviral Drugs by T. N. Komarov, M. V. Belova, D. D. Stolyarova, I. E. Shohin, D. S. Bogdanova, O. A. Miskiv, Yu. V. Medvedev, I. M. Korenskaya

    Published 2019-11-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    Hygienic Monitoring of Working Area Air Pollution by Particulate Matter of ticagrelator in the Pharmaceutical Factory

    Hygienic Monitoring of Working Area Air Pollution by Particulate Matter of ticagrelator in the Pharmaceutical Factory by I. A. Pozharnov, A. S. Simakov, N. A. Shulga, A. Yu. Savchenko, O. I. Perederyaev, L. S. Synkova, Yu. V. Medvedev, E. N. Fisher

    Published 2022-05-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: